U.S (New York) – Report Ocean has recently published a comprehensive research report titled “Telmisartan Market” Research Report 2023-2031. This report delves deep into the market and offers valuable insights into (Key Market Trends, Emerging Technologies, Market Drivers and Challenges of the Industry, Regulatory Policies), company profiles of key players, and their strategies. With over 100+ market data tables, pie charts, graphs, and figures, this global market study is now available. The report provides a thorough evaluation of the market, (Encompassing Future Trends, Current Growth Factors, Expert Opinions, Factual Information), and industry-validated market data, with a forecast extending until 2031.
The global telmisartan market was valued at $3,453 million in 2019, and is projected to reach $4,258 million by 2027, registering a CAGR of 3.4% from 2020 to 2027. The growth of the global telmisartan market is driven by surge in incidence of hypertension across the globe. Furthermore, rise in awareness related to complications associated with hypertension and cardiovascular is another major factor that fuels the growth of the market. In addition, surge in geriatric population and sedentary lifestyle act as key drivers of the global market. Moreover, increase in approval for abbreviated new drug application (ANDA) for manufacturing of generic telmisartan tablets and rise in cases of chronic kidney disease is expected to propel growth of telmisartan market.
Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1616
However, drug shortages are expected to restrain the growth of the telmisartan market. Conversely, surge in research related to telmisartan drug in emerging economies is expected to offer lucrative opportunities during the forecast period. Telmisartan drug is a non-peptide angiotensin receptor blocker (ARB) used alone or in combination with other agents such as hydrochlorothiazide and amlodipine, for treatment of hypertension. Moreover, it is used in treatment of cardiovascular risk reduction. Telmisartan is available in tablets of different strengths such as 20, 40 and 80 mg tablets under the trade name Micardis. In addition, telmisartan tablet is available in generic forms. The daily dose of telmisartan for hypertension is 40 to 80 mg and for cardiovascular risk reduction it is 80 mg. These drugs are prescribed by a physician, and are available in retail stores, online pharmacies, and hospital pharmacies.
The global telmisartan market is segmented into indication, distribution channel, and region. On the basis of indication, the market is categorized into hypertension and cardiovascular risk reduction. Depending on distribution channel, it is segregated into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA
According to data from the U.S. Bureau of Economic Analysis and the U.S. Census Bureau, the goods and services deficit increased by $1.9 billion from $68.7 billion in January 2023 to $70.5 billion in February. The increase in the goods and services deficit in February was due to a $2.7 billion increase in the goods deficit to $93.0 billion and a $0.8 billion increase in the services surplus to $22.4 billion. Compared to the same period in 2022, the goods and services deficit has dropped this year by $35.5 billion, or 20.3%. $49.5 billion or 10.8% more was exported. 2.2% or $14.0 billion more was spent on imports.
KEY BENEFITS FOR STAKEHOLDERS
– The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
– It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
– A comprehensive analysis of four regions is provided to determine the existing opportunities.
– The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
LIST OF KEY PLAYERS PROFILED IN THE REPORT
– Abbott Laboratories
– Aurobindo Pharma
– Boehringer Ingelheim International GmbH
– Cipla Inc.
– Glaxosmithkline Plc (GSK)
– Mylan N.V.
– Sanofi
– Sun Pharmaceutical Industries Limited
– Teva Pharmaceutical Industries Ltd. (Actavis Generics)
– Zydus Cadila
– Solco Healthcare
– Hikma Pharmaceuticals PLC
– Torrent Pharmaceuticals Ltd.
KEY MARKET SEGMENTS
By Indication
– Hypertension
– Cardiovascular Risk Reduction
By Distribution Channel
– Hospital Pharmacies
– Drug Stores and Retail Pharmacies
– Online Pharmacies
Request To Download Sample of This Strategic Report:- : https://reportocean.com/industry-verticals/sample-request?report_id=AMR1616
By Region
– North America
o U.S.
o Canada
o Mexico
– Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
– Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
– LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
Why Choose Report Ocean Reports?
Uncovering business opportunities: Our market research reports are invaluable for analyzing potential markets and identifying new product opportunities. They provide insights into customer needs, preferences, and attitudes, as well as facilitate product and service comparisons.
Gaining a clear understanding of your customers: Market reports offer a comprehensive understanding of customers’ needs and desires, empowering your company’s marketing department to enhance products, reduce costs, and improve promotional strategies based on this valuable information.
Data-driven insights: Our market research encompasses a broad spectrum of activities, including market size determination, demand forecasting, competitor analysis, and price monitoring. All these aspects are quantified and measurable, providing you with tangible data-driven insights that enable informed decision-making.
Key Highlights:
Revenue and Sales Estimation: Our reports present historical revenue and sales volume data, which is further triangulated using top-down and bottom-up approaches to forecast the complete market size. Additionally, the report provides estimates for key regions, along with well-recognized types and end-use industries. Macroeconomic factors and regulatory policies are also considered for industry evolution and predictive analysis.
Five Forces Analysis: To enhance market understanding, we conduct a comprehensive five forces analysis that includes evaluating the bargaining power of buyers and suppliers, the threat of new entrants, the threat of substitutes, and the level of rivalry within the market.
Competition: We study leading players in the industry based on their company profile, product portfolio, capacity, product/service pricing, sales performance, and cost/profit analysis.
Demand & Supply and Effectiveness: Our reports provide insights into distribution channels, production, consumption, and, if applicable, import and export activities.
Request full Report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1616
About US Report Ocean:
We are the best market research reports provider in the industry. Report Ocean is the world’s leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.
Get in Touch with Us:
Report Ocean:
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel: +1888 212 3539 (US – TOLL FREE)
Email: sales@reportocean.com
Visit our news website: https://reportocean.com